The prospective, randomized, double-blind, placebo-controlled Phase IIa trial is designed to enroll up about 24 patients with type 1 diabetes in-clinic for ten days. During the trial, patients
CSG is nephrology academic research organization with 300 affiliated clinics worldwide, while Medpace is contract research organization (CRO) with demonstrated expertise and experience in nephrology. NRX expects to
Currently, BUNAVAIL is under review at the US Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) date of 07 June 2014. If BUNAVAIL
Pursuant to the terms of the agreement, PACK Pharmaceuticals will receive $80m in cash and $5m in ACETO stock. In addition, the agreement provides for a three-year earn-out
Discovered by Takeda, TAK-438 belongs to a new class of acid secretion inhibitors called potassium-competitive acid blockers (P-CAB). In February 2014, a new drug application (NDA) for TAK-438
The deal leverages Xenon’s Extreme Genetics discovery platform to focus on rare phenotypes where individuals have an inability to perceive pain or where individuals have non-precipitated spontaneous severe
In 2013, Golden State Foods (GSF), a diversified food processors and distributors in the US, acquired a controlling interest in KanPak, a supplier of beverages and desserts using
MST-188 has already secured FDA orphan drug designation for the treatment of ALI, an acute complication of peripheral arterial disease that describes a sudden decrease in perfusion of
The new solution is aimed at helping providers and communities reduce hospital readmissions and re-incarcerations as well as help create more comprehensive patient health records. As of now,
NeoStem Grants and Academic Liaison director Dr Denis O. Rodgerson and Dr Vincent Falanga, The Barbara A. Gilchrest Professor of Dermatology and Professor of Biochemistry at the Boston
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.